Gliosarcoma
122 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors (NCT00187486) | University of California, San Francisco | 2004-08-01 |
| Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) (NCT00087451) | Merck Sharp & Dohme LLC | 2004-07-01 |
| Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols (NCT00035373) | National Cancer Institute (NCI) | 2002-04-19 |
| Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas (NCT00031083) | Biogen | 2002-04-02 |
Track Gliosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.